273 related articles for article (PubMed ID: 36643672)
1. Immunotherapy for the treatment of pediatric brain tumors: a narrative review.
Shalita C; Hanzlik E; Kaplan S; Thompson EM
Transl Pediatr; 2022 Dec; 11(12):2040-2056. PubMed ID: 36643672
[TBL] [Abstract][Full Text] [Related]
2. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy as a New Therapeutic Approach for Brain and Spinal Cord Tumors.
Medikonda R; Pant A; Lim M
Adv Exp Med Biol; 2023; 1394():73-84. PubMed ID: 36587382
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy for Pediatric Brain and Spine Tumors: Current State and Future Directions.
Estevez-Ordonez D; Gary SE; Atchley TJ; Maleknia PD; George JA; Laskay NMB; Gross EG; Devulapalli RK; Johnston JM
Pediatr Neurosurg; 2023; 58(5):313-336. PubMed ID: 36549282
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of CD22 chimeric antigen receptor (CAR) T cell therapy in patients with B cell malignancies: a protocol for a systematic review and meta-analysis.
Adeel K; Fergusson NJ; Shorr R; Atkins H; Hay KA
Syst Rev; 2021 Jan; 10(1):35. PubMed ID: 33478595
[TBL] [Abstract][Full Text] [Related]
6. Clinical advances in oncolytic virotherapy for pediatric brain tumors.
Ghajar-Rahimi G; Kang KD; Totsch SK; Gary S; Rocco A; Blitz S; Kachurak K; Chambers MR; Li R; Beierle EA; Bag A; Johnston JM; Markert JM; Bernstock JD; Friedman GK
Pharmacol Ther; 2022 Nov; 239():108193. PubMed ID: 35487285
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy for Medulloblastoma: Current Perspectives.
Kabir TF; Kunos CA; Villano JL; Chauhan A
Immunotargets Ther; 2020; 9():57-77. PubMed ID: 32368525
[TBL] [Abstract][Full Text] [Related]
8. New developments in immunotherapy for pediatric solid tumors.
Schultz LM; Majzner R; Davis KL; Mackall C
Curr Opin Pediatr; 2018 Feb; 30(1):30-39. PubMed ID: 29189429
[TBL] [Abstract][Full Text] [Related]
9. Systematic Review of Pediatric Brain Tumors in Neurofibromatosis Type 1: Status of Gene Therapy.
Thomas S; Bikeyeva V; Abdullah A; Radivojevic A; Abu Jad AA; Ravanavena A; Ravindra C; Igweonu-Nwakile EO; Ali S; Paul S; Yakkali S; Teresa Selvin S; Hamid P
Cureus; 2022 Aug; 14(8):e27963. PubMed ID: 36120213
[TBL] [Abstract][Full Text] [Related]
10. The effectiveness of interventions to treat severe acute malnutrition in young children: a systematic review.
Picot J; Hartwell D; Harris P; Mendes D; Clegg AJ; Takeda A
Health Technol Assess; 2012; 16(19):1-316. PubMed ID: 22480797
[TBL] [Abstract][Full Text] [Related]
11. Systemic treatments for metastatic cutaneous melanoma.
Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
[TBL] [Abstract][Full Text] [Related]
12. Community first responders for out-of-hospital cardiac arrest in adults and children.
Barry T; Doheny MC; Masterson S; Conroy N; Klimas J; Segurado R; Codd M; Bury G
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012764. PubMed ID: 31323120
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy approaches for rare pediatric solid tumors: advances and future directions.
Fierro Pineda JC; Wedekind MF; Glod JW
Curr Opin Pediatr; 2023 Feb; 35(1):63-74. PubMed ID: 36420774
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy associated central nervous system complications in primary brain tumors.
Mantica M; Drappatz J
Front Oncol; 2023; 13():1124198. PubMed ID: 36874119
[TBL] [Abstract][Full Text] [Related]
15. Chimeric antigen receptor-engineered T-cell therapy for liver cancer.
Chen Y; E CY; Gong ZW; Liu S; Wang ZX; Yang YS; Zhang XW
Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):301-309. PubMed ID: 29861325
[TBL] [Abstract][Full Text] [Related]
16. Innovative and Promising Strategies to Enhance Effectiveness of Immunotherapy for CNS Tumors: Where Are We?
Quintarelli C; Camera A; Ciccone R; Alessi I; Del Bufalo F; Carai A; Del Baldo G; Mastronuzzi A; De Angelis B
Front Immunol; 2021; 12():634031. PubMed ID: 34163465
[TBL] [Abstract][Full Text] [Related]
17. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
